AI assistant
Fagron N.V. — Capital/Financing Update 2017
May 1, 2017
3949_iss_2017-04-30_e6849ff0-d3a3-4228-8e3c-93e0ca1cbeec.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands)1 , 30 April 2017
Fagron announces today that there are no changes in the Guarantor List in accordance with the Guarantee Declaration dated 12 June 2012 regarding the € 225,000,000 4.75% Bond with maturity date 2 July 2017. The Guarantor List, in accordance with Article 10.4 of the Guarantee Declaration, is available at investors.fagron.com.
In accordance with Condition 10 (b) of the Bonds a new Compliance Certificate is published. The Compliance Certificate is available at investors.fagron.com.
In case of inconsistencies, the Dutch press release prevails.
For more information: Constantijn van Rietschoten Chief Communications Officer Tel. +31 6 53 69 15 85 [email protected]
Fagron profile
Fagron is a leading global company active in pharmaceutical compounding and focused on delivering tailored pharmaceutical care to hospitals, pharmacies, clinics and patients in 32 countries around the world.
The Belgian company Fagron NV is located in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR'. The operational activities of Fagron are driven by the Dutch company Fagron BV. The head office of Fagron BV is located in Rotterdam.